Verition Fund Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Verition Fund Management's EXAS Position: Q1 2026 in Review
Verition Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,234,379 shares — an estimated $125M sold.
Verition Fund Management first reported a position in EXAS in Q2 2018 and held it in 22 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Verition Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 1,234,379 Exact Sciences shares in Q1 2026, an estimated $125M.
- Verition Fund Management first reported a position in Exact Sciences in Q2 2018 and held it in 22 quarters.
- Verition Fund Management's Exact Sciences position peaked at $125M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.